Articles > Dexcom
The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …
A new study published in the New England Journal of Medicine (NEJM) showed promising results for closed-loop insulin delivery systems, the journal and participating manufacturers reported last week.
GluBill and GluAnna interviewed Steve Pacelli, Executive Vice President of Strategy and Corporate Development at Dexcom, to get his perspective on the news about FDA approval for use of the G4 Platinum sensor on pediatric patients. What will be the biggest benefit for families with children living with type 1 diabetes in using this newly […]